181 related articles for article (PubMed ID: 32048534)
1. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
[No Abstract] [Full Text] [Related]
2. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
3. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D
Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406
[TBL] [Abstract][Full Text] [Related]
11. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
Chung RH; Kang CY
Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis to identify driving factors in colorectal cancer.
Xu X; Gong C; Wang Y; Hu Y; Liu H; Fang Z
Epigenomics; 2020 Sep; 12(18):1633-1650. PubMed ID: 32573269
[No Abstract] [Full Text] [Related]
13. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
Shen Y; Xiong W; Gu Q; Zhang Q; Yue J; Liu C; Wang D
Front Med (Lausanne); 2021; 8():654635. PubMed ID: 34109194
[No Abstract] [Full Text] [Related]
14. Development and validation of the trans-omics model for pancreatic adenocarcinoma.
Huang W; Weng W; Wu B; Ye T; Lin Z; Zhang Z; Shi K
Epigenomics; 2021 Jan; 13(1):15-30. PubMed ID: 33356543
[No Abstract] [Full Text] [Related]
15. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
Seal DB; Das V; Goswami S; De RK
Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433
[TBL] [Abstract][Full Text] [Related]
16. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Jia Y; Shen M; Zhou Y; Liu H
Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
[TBL] [Abstract][Full Text] [Related]
17. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
[TBL] [Abstract][Full Text] [Related]
18. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
19. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Yan Y; Gao R; Trinh TLP; Grant MB
Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
[No Abstract] [Full Text] [Related]
20. Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases.
Pineda S; Gomez-Rubio P; Picornell A; Bessonov K; Márquez M; Kogevinas M; Real FX; Van Steen K; Malats N
Hum Hered; 2015; 79(3-4):124-36. PubMed ID: 26201698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]